Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
49.52
+0.14 (0.28%)
Nov 13, 2026, 4:00 PM EST - Market closed
GRDN Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,457 | 1,449 | 1,228 | 1,046 | 908.91 | 792.07 | |
Revenue Growth | 4.85% | 17.93% | 17.42% | 15.10% | 14.75% | 7.63% |
Cost of Revenue | 1,130 | 1,156 | 984.04 | 837.88 | 723.04 | 630.81 |
Gross Profit | 327.08 | 292.72 | 244.37 | 208.31 | 185.87 | 161.27 |
Selling, General & Admin | 232.78 | 212.43 | 304.52 | 143.91 | 133.88 | 118.09 |
Operating Expenses | 232.78 | 212.43 | 304.52 | 143.91 | 133.88 | 131.12 |
Operating Income | 94.3 | 80.29 | -60.15 | 64.4 | 51.99 | 30.15 |
Interest Expense | -0.65 | -0.67 | -3.28 | -2.86 | -1.93 | -1.64 |
Other Non Operating Income (Expenses) | 3.17 | 1.39 | -0.28 | -0.37 | -0.4 | -0.19 |
EBT Excluding Unusual Items | 96.82 | 81.01 | -63.71 | 61.17 | 49.66 | 28.33 |
Other Unusual Items | -0.16 | -7.59 | -2.77 | -23.45 | - | - |
Pretax Income | 105.16 | 73.42 | -66.48 | 37.72 | 49.66 | 28.33 |
Income Tax Expense | 29.11 | 24.47 | 4.56 | - | - | - |
Earnings From Continuing Operations | 76.05 | 48.96 | -71.03 | 37.72 | 49.66 | 28.33 |
Minority Interest in Earnings | -1.28 | 0.26 | -16.25 | -13.82 | -14.24 | -12.01 |
Net Income | 74.77 | 49.22 | -87.29 | 23.9 | 35.42 | 16.31 |
Preferred Dividends & Other Adjustments | - | - | 22.76 | 23.9 | - | - |
Net Income to Common | 74.77 | 49.22 | -110.05 | - | 35.42 | 16.31 |
Net Income Growth | 327.77% | - | - | - | 117.12% | -18.20% |
Shares Outstanding (Basic) | 63 | 62 | 62 | - | - | - |
Shares Outstanding (Diluted) | 64 | 63 | 62 | - | - | - |
Shares Change | 0.38% | 2.08% | - | - | - | - |
EPS (Basic) | 1.18 | 0.79 | -1.77 | - | - | - |
EPS (Diluted) | 1.17 | 0.78 | -1.77 | - | - | - |
EPS Growth | 326.17% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 96.17 | 80.71 | 41.59 | 56.26 | 31.75 | 49.22 |
Free Cash Flow Per Share | 1.51 | 1.27 | 0.67 | - | - | - |
Gross Margin | 22.45% | 20.21% | 19.89% | 19.91% | 20.45% | 20.36% |
Operating Margin | 6.47% | 5.54% | -4.90% | 6.16% | 5.72% | 3.81% |
Profit Margin | 5.13% | 3.40% | -8.96% | - | 3.90% | 2.06% |
Free Cash Flow Margin | 6.60% | 5.57% | 3.39% | 5.38% | 3.49% | 6.21% |
EBITDA | 117.76 | 102.62 | -40.38 | 82.63 | 68.55 | 46.68 |
EBITDA Margin | 8.08% | 7.08% | -3.29% | 7.90% | 7.54% | 5.89% |
D&A For EBITDA | 23.46 | 22.34 | 19.77 | 18.23 | 16.56 | 16.53 |
EBIT | 94.3 | 80.29 | -60.15 | 64.4 | 51.99 | 30.15 |
EBIT Margin | 6.47% | 5.54% | -4.90% | 6.16% | 5.72% | 3.81% |
Effective Tax Rate | 27.68% | 33.32% | - | - | - | - |